Ceruletide (INN), also known as cerulein or caerulein, is a ten amino acid oligopeptide that stimulates smooth muscle and ... Ceruletide was discovered and its structure elucidated in 1967 by Australian and Italian scientists from dried skins of the ... Ceruletide also activates NADPH oxidase, a source of reactive oxygen species contributing to inflammation, as well as the Janus ... Ceruletide is similar in action and composition to cholecystokinin. It stimulates gastric, biliary, and pancreatic secretion; ...
Caerulein, Ceruletide - 1 mg. Cat.Number : AS-24252 €240.00 Excl. Tax ...
Ceruletide 17650-98-5. 99.96%. Ceruletide is a decapeptide and a potent cholecystokinin receptor agonist. Ceruletide is a safe ...
CERULETIDE DIETHYLAMINE 51015 CETALKONIUM CHLORIDE 51016 CETEARETH 51017 CETEARYL OCTANOATE 51018 CETRIMONIUM BROMIDE 51020 ...
ceruletide - pharmacology. 1. channel. 1. channels. 1. charcot-marie- tooth. 1. charcot-marie-tooth. 1. ...
Ceruletide. MCM1 Protein. Minichromosome Maintenance 1 Protein. D13 - Nucleic Acids, Nucleotides, and Nucleosides. RNA, Long ...
Ceruletide. MCM1 Protein. Minichromosome Maintenance 1 Protein. D13 - Nucleic Acids, Nucleotides, and Nucleosides. RNA, Long ...
Ceruletide. MCM1 Protein. Minichromosome Maintenance 1 Protein. D13 - Nucleic Acids, Nucleotides, and Nucleosides. RNA, Long ...
Ceruletide. MCM1 Protein. Minichromosome Maintenance 1 Protein. D13 - Nucleic Acids, Nucleotides, and Nucleosides. RNA, Long ...
Ceruletide. MCM1 Protein. Minichromosome Maintenance 1 Protein. D13 - Nucleic Acids, Nucleotides, and Nucleosides. RNA, Long ...
Ceruletide. MCM1 Protein. Minichromosome Maintenance 1 Protein. D13 - Nucleic Acids, Nucleotides, and Nucleosides. RNA, Long ...
Ceruletide. MCM1 Protein. Minichromosome Maintenance 1 Protein. D13 - Nucleic Acids, Nucleotides, and Nucleosides. RNA, Long ...
Schilder, J. M., Thompson, A. M., DePriest, P. D., Ueland, F. R., Cibull, M. L., Kryscio, R. J., Modesitt, S. C., Lu, K. H., Geisler, J. P., Higgins, R. V., Magtibay, P. M., Cohn, D. E., Powell, M. A., Chu, C., Stehman, F. B. & Van Nagell, J., 2002, In: Gynecologic Oncology. 87, 1, p. 1-7 7 p.. Research output: Contribution to journal › Article › peer-review ...
Schumann, G., Liu, C., OReilly, P., Gao, H., Song, P., Xu, B., Ruggeri, B., Amin, N., Jia, T., Preis, S., Lepe, M. S., Akira, S., Barbieri, C., Baumeister, S., Cauchi, S., Clarke, T. K., Enroth, S., Fischer, K., Hällfors, J., Harris, S. E., & 107 othersHieber, S., Hofer, E., Hottenga, J. J., Johansson, Å., Joshi, P. K., Kaartinen, N., Laitinen, J., Lemaitre, R., Loukola, A., Luan, J., Lyytikäinen, L. P., Mangino, M., Manichaikul, A., Mbarek, H., Milaneschi, Y., Moayyeri, A., Mukamal, K., Nelson, C., Nettleton, J., Partinen, E., Rawal, R., Robino, A., Rose, L., Sala, C., Satoh, T., Schmidt, R., Schraut, K., Scott, R., Smith, A. V., Starr, J. M., Teumer, A., Trompet, S., Uitterlinden, A. G., Venturini, C., Vergnaud, A. C., Verweij, N., Vitart, V., Vuckovic, D., Wedenoja, J., Yengo, L., Yu, B., Zhang, W., Zhao, J. H., Boomsma, D. I., Chambers, J., Chasman, D. I., Daniela, T., De Geus, E., Deary, I., Eriksson, J. G., Esko, T., Eulenburg, V., Franco, O. H., Froguel, P., Gieger, C., Grabe, H. J., ...
Luo, Y., Yang, Y., Liu, M., Wang, D., Wang, F., Bi, Y., Ji, J., Li, S., Liu, Y., Chen, R., Huang, H., Wang, X., Swidnicka-Siergiejko, A. K., Janowitz, T., Beyaz, S., Wang, G., Xu, S., Bialkowska, A. B., Luo, C. K., Pin, C. L., & 14 othersLiang, G., Lu, X., Wu, M., Shroyer, K. R., Wolff, R. A., Plunkett, W., Ji, B., Li, Z., Li, E., Li, X., Yang, V. W., Logsdon, C. D., Abbruzzese, J. L. & Lu, W., Nov 2019, In: Gastroenterology. 157, 5, p. 1413-1428.e11. Research output: Contribution to journal › Article › peer-review ...
Ceruletide Medicine and Dentistry 100% * Mouse Pharmacology, Toxicology and Pharmaceutical Science 100% ...
Ceruletide Medicine & Life Sciences 49% * Neutralizing Antibodies Medicine & Life Sciences 36% * STAT3 Transcription Factor ...
Ceruletide Medicine & Life Sciences 27% * Transforming Growth Factors Medicine & Life Sciences 14% ...
Ceruletide Medicine and Dentistry 66% * Mutant Medicine and Dentistry 55% * Cell Type Medicine and Dentistry 44% ...
Ceruletide Medicine & Life Sciences 50% * Acinar Cells Medicine & Life Sciences 44% * Protein Chemical Compounds 30% ...
There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page. ...
Ceruletide and Alpha-1 Antitrypsin as a Novel Combination Therapy for Ischemic Stroke. Neurotherapeutics. DOI: 10.1007/s13311- ...
1986) Paradoxical response of sphincter of Oddi to intravenous injection of cholecystokinin or ceruletide. Manometric findings ...
Evaluation of the function of the exocrine pancreas in childhood by stimulation with ceruletide and secretin] 1985 SANTINI B; ... Evaluation of the function of the exocrine pancreas in childhood by stimulation with ceruletide and secretin]. ...
Some small molecular compounds are usually used as inducers for animal models, such as Ceruletide for inflammatory model, ...
A drug combination (CA) formed by ceruletide and alpha-1 antitrypsin showing a predicted value of neuroprotection of 92% was ... Ceruletide and Alpha-1 Antitrypsin as a Novel Combination Therapy for Ischemic Stroke. ... Finally, we identified the predicted mechanisms of action of ceruletide and alpha-1 antitrypsin and we demonstrated that CA ...
Caerulein use Ceruletide Caerulein Receptors use Receptors, Cholecystokinin Caeruloplasmin use Ceruloplasmin Caesalpinia ...
Ceruletide (Rec.INN) * Cobicistat (Rec.INN) * Copper Sulfate (Ph. Eur.) * Corticorelin (Rec.INN) ...